Literature DB >> 24320540

The application of sparse arrays in high frequency transcranial focused ultrasound therapy: a simulation study.

Daniel Pajek1, Kullervo Hynynen.   

Abstract

PURPOSE: Transcranial focused ultrasound is an emerging therapeutic modality that can be used to perform noninvasive neurosurgical procedures. The current clinical transcranial phased array operates at 650 kHz, however the development of a higher frequency array would enable more precision, while reducing the risk of standing waves. However, the smaller wavelength and the skull's increased distortion at this frequency are problematic. It would require an order of magnitude more elements to create such an array. Random sparse arrays enable steering of a therapeutic array with fewer elements. However, the tradeoffs inherent in the use of sparsity in a transcranial phased array have not been systematically investigated and so the objective of this simulation study is to investigate the effect of sparsity on transcranial arrays at a frequency of 1.5 MHz that provides small focal spots for precise exposure control.
METHODS: Transcranial sonication simulations were conducted using a multilayer Rayleigh-Sommerfeld propagation model. Element size and element population were varied and the phased array's ability to steer was assessed.
RESULTS: The focal pressures decreased proportionally as elements were removed. However, off-focus hotspots were generated if a high degree of steering was attempted with very sparse arrays. A phased array consisting of 1588 elements 3 mm in size, a 10% population, was appropriate for steering up to 4 cm in all directions. However, a higher element population would be required if near-skull sonication is desired.
CONCLUSIONS: This study demonstrated that the development of a sparse, hemispherical array at 1.5 MHz could enable more precision in therapies that utilize lower intensity sonications.

Mesh:

Year:  2013        PMID: 24320540      PMCID: PMC3855063          DOI: 10.1118/1.4829510

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  50 in total

1.  Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain.

Authors:  Hao-Li Liu; Mu-Yi Hua; Hung-Wei Yang; Chiung-Yin Huang; Po-Chun Chu; Jia-Shin Wu; I-Chou Tseng; Jiun-Jie Wang; Tzu-Chen Yen; Pin-Yuan Chen; Kuo-Chen Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

2.  3D models of blood flow in the cerebral vasculature.

Authors:  S Moore; T David; J G Chase; J Arnold; J Fink
Journal:  J Biomech       Date:  2005-06-13       Impact factor: 2.712

3.  Sparse 2-D array design for real time rectilinear volumetric imaging.

Authors:  J T Yen; J P Steinberg; S W Smith
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2000       Impact factor: 2.725

4.  High power transcranial beam steering for ultrasonic brain therapy.

Authors:  M Pernot; J F Aubry; M Tanter; J L Thomas; M Fink
Journal:  Phys Med Biol       Date:  2003-08-21       Impact factor: 3.609

5.  Non-invasive ultrasonic surgery of the brain in non-human primates.

Authors:  Fabrice Marquet; Anne-Laure Boch; Mathieu Pernot; Gabriel Montaldo; Danielle Seilhean; Mathias Fink; Mickael Tanter; Jean-Francois Aubry
Journal:  J Acoust Soc Am       Date:  2013-08       Impact factor: 1.840

6.  Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound.

Authors:  Emmanuel Thévenot; Jessica F Jordão; Meaghan A O'Reilly; Kelly Markham; Ying-Qi Weng; Kevin D Foust; Brian K Kaspar; Kullervo Hynynen; Isabelle Aubert
Journal:  Hum Gene Ther       Date:  2012-10-15       Impact factor: 5.695

7.  Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications.

Authors:  Kullervo Hynynen; Nathan McDannold; Nickolai A Sheikov; Ferenc A Jolesz; Natalia Vykhodtseva
Journal:  Neuroimage       Date:  2005-01-01       Impact factor: 6.556

8.  Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption.

Authors:  Manabu Kinoshita; Nathan McDannold; Ferenc A Jolesz; Kullervo Hynynen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

9.  MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study.

Authors:  Nir Lipsman; Michael L Schwartz; Yuexi Huang; Liesly Lee; Tejas Sankar; Martin Chapman; Kullervo Hynynen; Andres M Lozano
Journal:  Lancet Neurol       Date:  2013-03-21       Impact factor: 44.182

10.  A pilot study of focused ultrasound thalamotomy for essential tremor.

Authors:  W Jeffrey Elias; Diane Huss; Tiffini Voss; Johanna Loomba; Mohamad Khaled; Eyal Zadicario; Robert C Frysinger; Scott A Sperling; Scott Wylie; Stephen J Monteith; Jason Druzgal; Binit B Shah; Madaline Harrison; Max Wintermark
Journal:  N Engl J Med       Date:  2013-08-15       Impact factor: 91.245

View more
  6 in total

Review 1.  Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability.

Authors:  Dallan McMahon; Charissa Poon; Kullervo Hynynen
Journal:  Expert Opin Drug Deliv       Date:  2019-01-29       Impact factor: 6.648

Review 2.  Image-guided ultrasound phased arrays are a disruptive technology for non-invasive therapy.

Authors:  Kullervo Hynynen; Ryan M Jones
Journal:  Phys Med Biol       Date:  2016-08-05       Impact factor: 3.609

Review 3.  Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound.

Authors:  Charissa Poon; Dallan McMahon; Kullervo Hynynen
Journal:  Neuropharmacology       Date:  2016-02-18       Impact factor: 5.250

4.  Chirp- and random-based coded ultrasonic excitation for localized blood-brain barrier opening.

Authors:  H A S Kamimura; S Wang; S-Y Wu; M E Karakatsani; C Acosta; A A O Carneiro; E E Konofagou
Journal:  Phys Med Biol       Date:  2015-10-07       Impact factor: 3.609

5.  A multi-frequency sparse hemispherical ultrasound phased array for microbubble-mediated transcranial therapy and simultaneous cavitation mapping.

Authors:  Lulu Deng; Meaghan A O'Reilly; Ryan M Jones; Ran An; Kullervo Hynynen
Journal:  Phys Med Biol       Date:  2016-11-15       Impact factor: 3.609

Review 6.  "Focused Ultrasound-mediated Drug Delivery in Humans - a Path Towards Translation in Neurodegenerative Diseases".

Authors:  Joanna M Wasielewska; Anthony R White
Journal:  Pharm Res       Date:  2022-03-07       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.